See important safety & full prescribing information. Fda approved in mid october Fda label information for this drug is available at dailymed
Basal cell carcinoma (bcc) (a type of skin cancer). Libtayo will be a game changer for head and neck squamous cell cancer Cemiplimab is a newer cancer treatment that has brought hope to patients with advanced skin and lung cancers
Cemiplimab is approved by the u.s Food and drug administration (fda) to treat advanced forms of skin cancers, including cutaneous squamous. Review important safety info & full prescribing information including med guide.
